| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/29/2009 | US20090028890 encodes an HIV-1 MA polypeptide myristate binding site; capable of selectively eliciting a substantially th-1 immune response to HIV-1; vaccine |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028884 Oligomeric receptor ligand pair member complexes |
| 01/29/2009 | US20090028883 Novel P-selectin Ligand Protein |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028874 Synthetic Protein as Tumor-Specific Vaccine |
| 01/29/2009 | US20090028865 Method of treating hepatocellular carcinoma |
| 01/29/2009 | US20090028864 L-amino acid oxidase with cytotoxic activity from aplysia functata |
| 01/29/2009 | US20090028863 Markers for diagnosis of cancer and its use |
| 01/29/2009 | US20090028861 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 01/29/2009 | US20090028856 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
| 01/29/2009 | US20090028822 Glycopegylated Interferon Alpha |
| 01/29/2009 | US20090028821 Prodrugs of cc-a1065 analogs |
| 01/29/2009 | US20090028813 Methods for Treating Body Tissue |
| 01/29/2009 | US20090028793 Vascular Tumor Markers |
| 01/29/2009 | US20090028790 Labelled adrenomedullin derivatives and their use for imaging and therapy |
| 01/29/2009 | CA2694466A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | CA2694396A1 Targeted binding agents directed to kdr and uses thereof - 035 |
| 01/29/2009 | CA2694214A1 Peptides derived from plasminogen activator inhibitor-1 and uses thereof |
| 01/29/2009 | CA2694047A1 Use of mutated antithrombins for treating or preventing coagulation disorders |
| 01/29/2009 | CA2694001A1 Complexes of grp94 with human immunoglobulin g |
| 01/29/2009 | CA2693951A1 Growth hormone fusion proteins |
| 01/29/2009 | CA2693277A1 Immune modulation via c-type lectin |
| 01/29/2009 | CA2692777A1 Plants having increased yield-related traits and a method for making the same |
| 01/29/2009 | CA2685308A1 Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
| 01/28/2009 | EP2019148A1 Gene mapping method using microsatellite genetic polymorphism markers |
| 01/28/2009 | EP2019144A1 Vector particles for targeting CD34+ cells |
| 01/28/2009 | EP2019142A2 Isoforms of elF-5A and methods of using same |
| 01/28/2009 | EP2019141A2 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 01/28/2009 | EP2019140A2 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 01/28/2009 | EP2019139A1 WT1 interacting protein WTIP |
| 01/28/2009 | EP2019118A1 Method for synthesizing thymosins |
| 01/28/2009 | EP2019117A1 Optimized purification process of recombinant growth factor protein |
| 01/28/2009 | EP2019116A1 Inhibitor of the met-receptor and its use |
| 01/28/2009 | EP2019115A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/28/2009 | EP2018871A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 01/28/2009 | EP2018424A2 Methods and compositions for inactivation of dihydrofolate reductase |
| 01/28/2009 | EP2018397A2 MOLECULAR CLONING AND SEQUENCING OF ACETYL CoA CARBOXYLASE (ACCase) GENE FROM JATROPHA CURCAS |
| 01/28/2009 | EP2018396A1 Modelling in yeast of the mitochondrial atp6 gene mutations responsible for narp syndrome in humans and uses thereof for screening for medicaments |
| 01/28/2009 | EP1917275A4 Modulating the kv1.1 voltage-gated potassium channel in t-cells for regulating the synthesis and secretion of tumor necrosis factor (tnf- ) and treating human diseases or injuries mediated by detrimentally high or low levels of tnf- |
| 01/28/2009 | EP1725580B1 Isosteric transformation |
| 01/28/2009 | EP1682572A4 Protein expression |
| 01/28/2009 | EP1662863A4 Transgenic tieg non-human animals |
| 01/28/2009 | EP1539815B1 Crystal structure of an angiotensin-converting enzyme (ace) and uses thereof |
| 01/28/2009 | EP1446426B1 Peptide purification by means of metal ion affinity chromatography |
| 01/28/2009 | EP1379658B1 Antimicrobial peptides and methods of use |
| 01/28/2009 | EP1255773B1 Insecticidal proteins from bacillus thuringiensis |
| 01/28/2009 | CN101356279A DOF (DNA binding with one finger) sequences and methods of use |
| 01/28/2009 | CN101356274A Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870 |
| 01/28/2009 | CN101356273A Global transcription machinery engineering |
| 01/28/2009 | CN101356271A Identification and discrimination of function interdiction anti-ED-B-fibronectin antibody |
| 01/28/2009 | CN101356270A Nuclear reprogramming factor |
| 01/28/2009 | CN101356269A Methods for expression and purification of recombinant human growth hormone |
| 01/28/2009 | CN101356265A Productivity augmenting protein factor, novel cell lines and uses thereof |
| 01/28/2009 | CN101356193A Inhibition of the anti-FVIII immune response |
| 01/28/2009 | CN101356192A Compositions and methods for modulating hemostasis |
| 01/28/2009 | CN101356191A Neuropeptides for the culture of aquatic organisms |
| 01/28/2009 | CN101356190A Antagonists against interaction of PF4 and RANTES |
| 01/28/2009 | CN101356189A Hepatocyte growth factor intron fusion proteins |
| 01/28/2009 | CN101356188A Plants having improved growth characteristics and a method for making the same |
| 01/28/2009 | CN101355963A Marked bovine viral diarrhea virus vaccines |
| 01/28/2009 | CN101355928A Compositions and methods for cancer immunotherapy |
| 01/28/2009 | CN101353706A Adenovirus-transfected primary cells and methods of pathway mapping |
| 01/28/2009 | CN101353685A Zein active peptide and preparation technique thereof |
| 01/28/2009 | CN101353668A Mouse beta-alexin 1 recombinant plasmids, polypeptides, uses and preparations thereof |
| 01/28/2009 | CN101353659A Method for preparing dissolvable high activity recombinant human epidermal growth factor |
| 01/28/2009 | CN101353633A Lactobacillus plantarum ZJ316, procreant antibiotic peptides, preparation and use thereof |
| 01/28/2009 | CN101353380A Jellyfish origin immune activity enhanced collagen peptide, preparation and use thereof |
| 01/28/2009 | CN101353379A Protein modified biological-inorganic nano composite material and preparation thereof |
| 01/28/2009 | CN101353378A Zone 2 protein of programmed cell death protein 2 analogue and uses thereof |
| 01/28/2009 | CN101353377A Zone 1 protein of programmed cell death protein 2 analogue and uses thereof |
| 01/28/2009 | CN101353376A Protein related to rice ear sprouting period and encoding genes and uses thereof |
| 01/28/2009 | CN101353375A Method for producing influenza hemagglutinin multivalent vaccine |
| 01/28/2009 | CN101353374A Pronucleus expressed hepatitis a virus recombinant antigen |
| 01/28/2009 | CN101353373A Synthetic peptide vaccines for foot-and-mouth disease |
| 01/28/2009 | CN101353372A Novel protein molecular orientation evolvement method |
| 01/28/2009 | CN100455666C Synergistic control Gene of AtbHLH29 for plant ferro element absorb and its coded protein and uses |
| 01/28/2009 | CN100455600C Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 01/28/2009 | CN100455597C Process of high purity albumin production |
| 01/28/2009 | CN100455596C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/28/2009 | CN100455595C Protein of interreaction with karyomitosis primary activator protein kinase p38 and its coding gene and application |
| 01/28/2009 | CN100455594C Polypeptide of controlling IIIv virus fusion and its use |
| 01/27/2009 | US7482511 Transcription factor stress-related proteins and methods of use in plants |
| 01/27/2009 | US7482510 expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress (drought, cold, oxidation) |
| 01/27/2009 | US7482508 Providing cells of cotton plants with chimeric gene comprising operably linked DNA fragments (which contain promoter, enzyme, and region involved with transcription termination and polyadenylation); transgenic cells, seeds, plants |
| 01/27/2009 | US7482506 Ras p27 mouse models and uses thereof |
| 01/27/2009 | US7482442 HEMCM42 nucleic acids |
| 01/27/2009 | US7482440 Hemopoietin receptor protein, NR10 |
| 01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/27/2009 | US7482435 Immunoglobulin for use in human therapeutics and diagnostics |
| 01/27/2009 | US7482432 Protein for use as tool in controlling plant pest; pesticides; biological pest control; moths and beetles |
| 01/27/2009 | US7482431 KCNQ2 potassium channels |
| 01/27/2009 | US7482430 Modified tumor necrosis factor receptor for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 01/27/2009 | US7482428 Optimized expression of HPV 31 L1 in yeast |
| 01/27/2009 | US7482427 Synthetic peptides having a non growth factor heparin binding region, a linker, and sequences; treatment of bone lesions, degenerative joint disease and to enhance bone formation |
| 01/27/2009 | US7482426 C23 Polypeptides |
| 01/27/2009 | US7482425 Compositions for lipid matrix-assisted chemical ligation |
| 01/27/2009 | US7482331 Treating myocardial failure in a human by administering an effective amount of a transgene encoding for alpha-MHC, wherein expression of alpha-MHC provides improvement in left ventricular ejection fraction |
| 01/27/2009 | US7482329 Structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like (tissue differentiation factor) receptors; methods of detecting, preventing, and treating TDF-associated disorders |
| 01/27/2009 | US7482328 an artificially synthesized antimicrobial polypeptide that does not occur in nature contains in its peptide chain one or more types of nuclear localization signal sequences (NLSs); for drug resistance bacteria |